,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1268338,439213,Therapeutic Target Database (TTD),D-Glucosamine,D07NSU,Glucosamine,https://idrblab.net/ttd/data/drug/details/D07NSU,T42000,Interleukin-1 beta (IL1B),https://idrblab.net/ttd/data/target/details/T42000,P01584,Interleukin-1 beta,3553,IL1B,9606,Homo sapiens (human),Inhibitor,,,,,,,
1,1268441,439213,Drug Gene Interaction database (DGIdb),D-Glucosamine,,GLUCOSAMINE,https://www.dgidb.org/drugs/GLUCOSAMINE,,IL1B,https://www.dgidb.org/genes/IL1B,,,3553,IL1B,9606,Homo sapiens (human),,,,,,,,
2,1296218,439213,DrugBank,D-Glucosamine,DB01296,Glucosamine,https://www.drugbank.ca/drugs/DB01296,BE0000944,Interferon gamma,https://www.drugbank.ca/bio_entities/BE0000944,P01579,Interferon gamma,3458,IFNG,9606,Homo sapiens (human),Inhibitor,,,PMID:16155294|PMID:16431966|PMID:16709188|PMID:17238806,https://www.ncbi.nlm.nih.gov/pubmed/16155294|https://www.ncbi.nlm.nih.gov/pubmed/16431966|https://www.ncbi.nlm.nih.gov/pubmed/16709188|https://www.ncbi.nlm.nih.gov/pubmed/17238806,16155294|16431966|16709188|17238806,,"Sarrazin S, Bonnaffe D, Lubineau A, Lortat-Jacob H: Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity. J Biol Chem. 2005 Nov 11;280(45):37558-64. Epub 2005 Sep 9.|Chen JT, Liang JB, Chou CL, Chien MW, Shyu RC, Chou PI, Lu DW: Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 2006 Feb;47(2):664-72.|Lortat-Jacob H: Interferon and heparan sulphate. Biochem Soc Trans. 2006 Jun;34(Pt 3):461-4.|Chen JT, Chen CH, Horng CT, Chien MW, Lu DW, Liang JB, Tai MC, Chang YH, Chen PL, Chen YH: Glucosamine sulfate inhibits proinflammatory cytokine-induced icam-1 production in human conjunctival cells in vitro. J Ocul Pharmacol Ther. 2006 Dec;22(6):402-16."
3,1296219,439213,DrugBank,D-Glucosamine,DB01296,Glucosamine,https://www.drugbank.ca/drugs/DB01296,BE0005551,Transcription factor p65,https://www.drugbank.ca/bio_entities/BE0005551,Q04206,Transcription factor p65,5970,RELA,9606,Homo sapiens (human),Inhibitor,,,PMID:16431966|PMID:16822504,https://www.ncbi.nlm.nih.gov/pubmed/16431966|https://www.ncbi.nlm.nih.gov/pubmed/16822504,16431966|16822504,,"Chen JT, Liang JB, Chou CL, Chien MW, Shyu RC, Chou PI, Lu DW: Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. Invest Ophthalmol Vis Sci. 2006 Feb;47(2):664-72.|Chen JT, Chen PL, Chang YH, Chien MW, Chen YH, Lu DW: Glucosamine sulfate inhibits leukocyte adhesion in response to cytokine stimulation of retinal pigment epithelial cells in vitro. Exp Eye Res. 2006 Nov;83(5):1052-62. doi: 10.1016/j.exer.2006.05.010. Epub 2006 Jul 5."
4,1296220,439213,DrugBank,D-Glucosamine,DB01296,Glucosamine,https://www.drugbank.ca/drugs/DB01296,BE0001045,"Solute carrier family 2, facilitated glucose transporter member 2",https://www.drugbank.ca/bio_entities/BE0001045,P11168,"Solute carrier family 2, facilitated glucose transporter member 2",6514,SLC2A2,9606,Homo sapiens (human),Substrate,,,PMID:12135767,https://www.ncbi.nlm.nih.gov/pubmed/12135767,12135767,,"Uldry M, Ibberson M, Hosokawa M, Thorens B: GLUT2 is a high affinity glucosamine transporter. FEBS Lett. 2002 Jul 31;524(1-3):199-203. doi: 10.1016/s0014-5793(02)03058-2."
5,1296221,439213,DrugBank,D-Glucosamine,DB01296,Glucosamine,https://www.drugbank.ca/drugs/DB01296,BE0001057,"Solute carrier family 2, facilitated glucose transporter member 1",https://www.drugbank.ca/bio_entities/BE0001057,P11166,"Solute carrier family 2, facilitated glucose transporter member 1",6513,SLC2A1,9606,Homo sapiens (human),Substrate,,,PMID:23506862|PMID:22993875,https://www.ncbi.nlm.nih.gov/pubmed/23506862|https://www.ncbi.nlm.nih.gov/pubmed/22993875,23506862|22993875,,"Mueckler M, Thorens B: The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):121-38. doi: 10.1016/j.mam.2012.07.001.|Chopra A: cypate-d: -(+)-glucosamine (cyp-GlcN), and d: -(+)-glucosamine-cypate-d: -(+)-glucosamine (cyp-2GlcN) ."
6,1296222,439213,DrugBank,D-Glucosamine,DB01296,Glucosamine,https://www.drugbank.ca/drugs/DB01296,BE0000893,"Solute carrier family 2, facilitated glucose transporter member 4",https://www.drugbank.ca/bio_entities/BE0000893,P14672,"Solute carrier family 2, facilitated glucose transporter member 4",6517,SLC2A4,9606,Homo sapiens (human),Substrate,,,PMID:23506862,https://www.ncbi.nlm.nih.gov/pubmed/23506862,23506862,,"Mueckler M, Thorens B: The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013 Apr-Jun;34(2-3):121-38. doi: 10.1016/j.mam.2012.07.001."
7,1296223,439213,DrugBank,D-Glucosamine,DB01296,Glucosamine,https://www.drugbank.ca/drugs/DB01296,BE0004707,"Solute carrier family 2, facilitated glucose transporter member 3",https://www.drugbank.ca/bio_entities/BE0004707,P11169,"Solute carrier family 2, facilitated glucose transporter member 3",6515,SLC2A3,9606,Homo sapiens (human),Substrate,,,PMID:22993875,https://www.ncbi.nlm.nih.gov/pubmed/22993875,22993875,,"Chopra A: cypate-d: -(+)-glucosamine (cyp-GlcN), and d: -(+)-glucosamine-cypate-d: -(+)-glucosamine (cyp-2GlcN) ."
